1,057 hedge funds and large institutions have $36.2B invested in Biogen in 2020 Q2 according to their latest regulatory filings, with 96 funds opening new positions, 338 increasing their positions, 437 reducing their positions, and 130 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

26% less first-time investments, than exits

New positions opened: 96 | Existing positions closed: 130

37% less call options, than puts

Call options by funds: $894M | Put options by funds: $1.43B

57% less funds holding in top 10

Funds holding in top 10: 4921 (-28)

Holders
1,057
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$894M
Puts
$1.43B
Net Calls
Net Calls Change

Top Buyers

1 +$182M
2 +$148M
3 +$142M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$114M
5
AL
AJO LP
Pennsylvania
+$91.1M
Name Holding Trade Value Shares
Change
Change in
Stake
826
$241K
827
$237K
828
$235K
829
$234K
830
$233K
831
$232K
832
$231K
833
$230K
834
$228K
835
$226K
836
$224K
837
$223K
838
$222K
839
$222K
840
$221K
841
$221K
842
$219K
843
$219K
844
$219K
845
$218K
846
$217K
847
$215K
848
$214K
849
$214K
850
$214K